Iridium Complex-Catalyzed Allylic Amination
J. Am. Chem. Soc., Vol. 123, No. 39, 2001 9533
J ) 16.3, 2.0 Hz, 1H), 5.18 (dd, J ) 10.2, 2.0 Hz, 1H), 5.65 (ddd, J
) 16.3, 10.2, 7.9 Hz, 1H).
5.13 (dd, J ) 17.2, 2.2 Hz, 1H), 5.21 (dd, J ) 10.3, 2.2 Hz, 1H), 5.84
(ddd, J ) 17.2, 10.3, 6.9 Hz, 1H).
N-(1-n-Hexyl-2-propenyl)cyclopentylamine (14ad). 1H NMR (400
MHz, C6D6) δ 0.88 (t, J ) 7.1 Hz, 3H), 1.25-1.47 (m, 15 H), 1.62-
1.82 (m, 4H), 2.96-3.00 (m, 1H), 3.13 (quintet, J ) 6.5 Hz, 1H), 5.02
(dd, J ) 10.1, 2.0 Hz, 1H), 5.04 (dd, J ) 17.2, 2.0 Hz, 1H), 5.54 (ddd,
J ) 17.2, 10.1, 8.1 Hz, 1H); 13C NMR (100 MHz, C6D6) δ 14.3, 23.0,
24.3 (2C), 26.3, 29.8, 32.3, 33.3, 34.5, 36.8, 57.0, 60.6, 114.4, 143.1.
Anal. Calcd for C14H27N: C, 80.31; H, 13.00; N, 6.69. Found: C, 80.56;
H, 13.16; N, 6.51.
1-[1-(n-Octyl)-2-propenyl]pyrrolidine (14bb). 1H NMR (400 MHz,
C6D6) δ 0.86 (t, J ) 7.1 Hz, 3H), 1.24-1.26 (m, 12H), 1.40-1.49 (m,
2H), 1.56-1.69 (m, 4H), 2.41-2.48 (m, 4H), 2.64 (td, J ) 8.6, 4.4
Hz, 1H), 5.01 (dd, J ) 10.2, 2.1 Hz, 1H), 5.04 (dd, J ) 17.2, 2.1 Hz,
1H), 5.75 (ddd, J ) 17.2, 10.2, 8.6 Hz, 1H); 13C NMR (100 MHz,
C6D6) δ 14.3, 23.1, 23.8 (2C), 26.2, 29.8, 30.1, 30.4, 32.3, 34.6, 51.4
(2C), 68.4, 115.6, 140.9. Anal. Calcd for C15H29N: C, 80.65; H, 13.08;
N, 6.27. Found: C, 80.43; H, 13.36; N, 6.12.
N-[(E)-2-Nonenyl]cyclopentylamine ((E)-15ad). Compound (E)-
15ad could not be isolated in a pure form. Partial H NMR spectra
1-[(E)-2-Undecenyl]pyrrolidine ((E)-15bb). Compound (E)-15bb
1
1
could not be isolated in a pure form. Partial H NMR spectra were
were obtained from the mixture of 14ad. 1H NMR (400 MHz, CDCl3)
δ 5.52 (dt, J ) 15.3, 5.7 Hz, 1H), 5.58 (dt, J ) 15.3, 5.2 Hz, 1H).
N-(1-n-Hexyl-2-propenyl)-n-butylamine (14ae). 1H NMR (400
MHz, CDCl3) δ 0.88 (t, J ) 7.2 Hz, 6H), 1.25-1.45 (m, 15H), 2.44
(dt, J ) 11.2, 6.6 Hz, 1H), 2.63 (dt, J ) 11.2, 6.8 Hz, 1H), 2.91 (q, J
) 7.9 Hz, 1H), 5.03 (dd, J ) 10.2, 2.0 Hz, 1H), 5.06 (dd, J ) 17.2,
2.0 Hz, 1H), 5.58 (ddd, J ) 17.2, 10.2, 7.9 Hz, 1H); 13C NMR (100
MHz, CDCl3) δ 14.24, 14.28, 20.9, 23.0, 26.3, 29.9, 32.2, 33.1, 36.4,
47.3, 62.4, 114.7, 142.9. Anal. Calcd for C13H27N: C, 79.11; H, 13.79;
N, 7.10. Found: C, 78.96; H, 13.83; N, 7.09.
obtained from the mixture of 14bb. 1H NMR (400 MHz, C6D6) δ 3.03
(d, J ) 5.3 Hz, 2H), 5.59 (dt, J ) 15.4, 6.3 Hz, 1H), 5.66 (dt, J )
15.4, 5.3 Hz, 1H).
1-[1-Cyclohexyl-2-propenyl]pyrrolidine (14cb). 1H NMR (400
MHz, C6D6) δ 0.91-1.31 (m, 4H), 1.50-1.77 (m, 10H), 1.98-2.00
(m, 1H), 2.42-2.47 (m, 5H), 5.00 (dd, J ) 17.2, 2.3 Hz, 1H), 5.07
(dd, J ) 10.3, 2.3 Hz, 1H), 5.73 (ddd, J ) 17.2, 10.3, 9.3 Hz, 1H); 13
C
NMR (100 MHz, C6D6) δ 23.7 (2C), 27.0, 27.1, 27.4, 28.5, 31.4, 40.9,
51.1 (2C), 73.4, 116.7, 138.1. Anal. Calcd for C13H23N: C, 80.76; H,
11.99; N, 7.25. Found: C, 80.99; H, 12.23; N, 7.17.
N-[(E)-2-Nonenyl]-n-butylamine ((E)-15ae). Compound (E)-15ae
1-[(E)-3-Cyclohexyl-2-propenyl]pyrrolidine ((E)-15cb). Compound
(E)-15cb could not be isolated in a pure form. Partial 1H NMR spectra
were obtained from the mixture of 14cb. 1H NMR (400 MHz, C6D6) δ
3.06 (d, J ) 5.4 Hz, 2H), 5.58 (dd, J ) 15.8, 6.0 Hz, 1H), 5.65 (dt, J
) 15.8, 5.4 Hz, 1H).
1
could not be isolated in a pure form. Partial H NMR spectra were
1
obtained from the mixture of 14ae. H NMR (400 MHz, CDCl3) δ
3.18 (d, J ) 5.8 Hz, 2H), 5.51 (dt, J ) 15.4, 5.9 Hz, 1H), 5.58 (dt, J
) 15.4, 5.8 Hz, 1H).
N-[(Z)-2-Nonenyl]-n-butylamine ((Z)-15ae). 1H NMR (400 MHz,
C6D6) δ 0.97-1.03 (m, 6H), 1.36-1.53 (m, 13H), 2.17 (q, J ) 7.3
Hz, 2H), 2.65 (t, J ) 5.9 Hz, 2H), 3.37 (d, J ) 6.6 Hz, 2H), 5.60 (dt,
J ) 10.9, 7.3 Hz, 1H), 5.68 (dt, J ) 10.6, 6.6 Hz, 1H); 13C NMR (67.8
MHz, CDCl3) δ 13.9, 14.0, 20.5, 22.6, 27.4, 28.9, 29.6, 31.7, 32.2,
46.3, 49.2, 128.0, 131.9. Anal. Calcd for C13H27N: C, 79.11; H, 13.79;
N, 7.10. Found: C, 79.11; H, 14.03; N, 7.01.
1
N-(1-Cyclohexyl-2-propenyl)aniline (14ci). H NMR (400 MHz,
CDCl3) δ 1.01-1.30 (m, 5H), 1.46-1.51 (m, 1H), 1.66-1.86 (m, 5H),
3.62-3.65 (m, 2H), 5.13 (d, J ) 10.3, 1.6 Hz, 1H), 5.16 (dd, J )
17.0, 1.6 Hz, 1H), 5.71 (ddd, J ) 17.0, 10.3, 6.6 Hz, 1H), 6.56-6.66
(m, 3H), 7.10-7.15 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 26.27,
26.33, 26.5, 29.3, 29.4, 42.7, 61.0, 113.2 (2C), 115.7, 116.9, 129.1
(2C), 138.3, 147.9. Anal. Calcd for C15H21N: C, 83.67; H, 9.83; N,
6.50. Found: C, 83.39; H, 10.03; N, 6.54.
1
N-[(Z)-2-Nonenyl]diethylamine ((Z)-15af). H NMR (400 MHz,
C6D6) δ 1.00 (t, J ) 7.1 Hz, 3H), 1.12 (t, J ) 7.1 Hz, 6H), 1.34-1.50
(m, 8H), 2.19 (q, J ) 7.1 Hz, 2H), 2.59 (q, J ) 7.1 Hz, 4H), 3.24 (d,
J ) 6.6 Hz, 2H), 5.63 (dtt, J ) 11.0, 7.1, 1.6 Hz, 1H), 5.75 (dtt, J )
11.0, 6.6, 1.5 Hz, 1H); 13C NMR (100 MHz, C6D6) δ 12.5 (2C), 14.2,
23.0, 27.9, 29.3, 30.1, 32.1, 47.2 (2C), 50.3, 128.4, 132.1. Anal. Calcd
for C13H27N: C, 79.11; H, 13.79; N, 7.10. Found: C, 79.14; H, 13.75;
N, 7.12.
N-((E)-3-Cyclohexyl-2-propenyl)aniline ((E)-15ci). Compound (E)-
15ci could not be isolated in a pure form. Partial 1H NMR spectra were
obtained from the mixture of 14ci. 1H NMR (400 MHz, CDCl3) δ 3.67
(d, J ) 5.8 Hz, 2H), 5.51 (dtd, J ) 15.5, 5.8, 1.0 Hz, 1H), 5.64 (dd,
J ) 15.5, 6.5 Hz, 1H).
1-[(Z)-6-Phenyl-2-hexenyl]piperidine ((Z)-15d). 1H NMR (400
MHz, C6D6) δ 1.32-1.38 (m, 2H), 1.54 (quintet, J ) 5.6 Hz, 4H),
1.60 (quintet, J ) 7.5 Hz, 2H), 2.03 (q, J ) 7.3 Hz, 2H), 2.32 (br,
4H), 2.49 (t, J ) 7.6 Hz, 2H), 2.91 (d, J ) 6.7 Hz, 2H), 5.49 (dtt, J )
11.0, 7.3, 1.6 Hz, 1H), 5.67 (dtt, J ) 11.0, 6.7, 1.6 Hz, 1H), 7.06-
7.20 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 24.3, 25.9 (2C), 27.0,
31.2, 35.4, 54.5 (2C), 55.9, 125.7, 127.0, 128.2 (2C), 128.4 (2C), 132.2,
142.3. Anal. Calcd for C17H25N: C, 83.89; H, 10.35; N, 5.75. Found:
C, 83.64; H, 10.65; N, 5.67.
N-[1-(n-Hexyl)-2-propenyl]diethylamine (14af). Compound 14af
1
could not be isolated in a pure form. Partial H NMR spectra were
1
obtained from the mixture of (Z)-15af. H NMR (400 MHz, C6D6) δ
5.11 (dd, J ) 17.2, 2.1 Hz, 1H), 5.20 (dd, J ) 10.4, 2.2 Hz, 1H), 5.81
(ddd, J ) 17.2, 10.4, 6.9 Hz, 1H).
N-[1-(n-Hexyl)-2-propenyl]aniline (14ai). 1H NMR (400 MHz,
CDCl3) δ 0.88 (t, J ) 7.0 Hz, 3H), 1.28-1.45 (m, 8H), 1.54-1.60 (m,
2H), 3.59 (br, 1H), 3.78 (q, J ) 6.2 Hz, 1H), 5.10 (dd, J ) 10.3, 1.3
Hz, 1H), 5.19 (d, J ) 17.2, 1.3 Hz, 1H), 5.72 (ddd, J ) 17.2, 10.3, 6.2
Hz, 1H), 6.56-6.69 (m, 3H), 7.11-7.18 (m, 2H); 13C NMR (100 MHz,
CDCl3) δ 14.0, 22.6, 25.9, 29.2, 31.7, 35.9, 55.9, 113.3 (2C), 114.9,
117.1, 129.1 (2C), 140.2, 147.7. Anal. Calcd for C15H23N: C, 82.89;
H, 10.67; N, 6.44. Found: C, 82.63; H, 10.87; N, 6.27.
1-[1-(3-Phenylpropyl)-2-propenyl]piperidine (14d). Compound
14d could not be isolated in a pure form. Partial 1H NMR spectra were
1
obtained from the mixture of (Z)-15d. H NMR (400 MHz, C6D6) δ
4.96 (dd, J ) 17.2, 2.1 Hz, 1H), 5.07 (dd, J ) 10.3, 2.1 Hz, 1H).
1
1-[(Z)-2,8-Nonadienyl]piperidine ((Z)-15e). H NMR (400 MHz,
C6D6) δ 1.24-1.37 (m, 6H), 1.54 (quintet, J ) 5.7 Hz, 4H), 1.93-
2.04 (m, 4H), 2.34 (br, 4H), 2.95 (d, J ) 6.7 Hz, 2H), 4.97 (ddt, J )
10.2, 2.0, 1.0 Hz, 1H), 5.02 (dq, J ) 17.1, 2.0 Hz, 1H), 5.48 (dtt, J )
11.0, 7.3, 1.5 Hz, 1H), 5.65 (dtt, J ) 11.0, 6.7, 1.5 Hz, 1H), 5.75 (ddt,
J ) 17.1, 10.2, 6.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 24.4,
26.0 (2C), 27.3, 28.5, 29.0, 33.6, 54.5 (2C), 55.9, 114.3, 126.6, 132.5,
138.9. Anal. Calcd for C14H25N: C, 81.09; H, 12.15; N, 6.75. Found:
C, 80.83; H, 12.42; N, 6.74.
1-[(Z)-5-Ethyl-2-nonenyl]piperidine ((Z)-15f). 1H NMR (400 MHz,
C6D6) δ 0.99 (t, J ) 7.0 Hz, 3H), 1.02 (t, J ) 6.7 Hz, 3H), 1.38-1.47
(m, 11H), 1.66 (quintet, J ) 5.6 Hz, 4H), 2.18-2.20 (m, 2H), 2.49 (t,
J ) 5.2 Hz, 4H), 3.12 (d, J ) 6.7 Hz, 2H), 5.65 (dtt, J ) 11.1, 7.3, 1.6
Hz, 1H), 5.81 (dtt, J ) 11.1, 6.7, 1.5 Hz, 1H); 13C NMR (67.8 MHz,
CDCl3) δ 11.0, 14.1, 23.0, 24.4, 25.8, 26.0 (2C), 29.0, 31.1, 32.7, 39.5,
54.6 (2C), 56.1, 127.2, 131.4. Anal. Calcd for C16H31N: C, 80.94; H,
13.16; N, 5.90. Found: C, 80.99; H, 13.12; N, 5.84.
N-[(E)-2-Nonenyl]aniline ((E)-15ai). Compound (E)-15ai could not
be isolated in a pure form. Partial 1H NMR spectra were obtained from
1
the mixture of 14ai. H NMR (400 MHz, C6D6) δ 5.38 (dt, J ) 15.3,
5.7 Hz, 1H), 5.53 (dt, J ) 15.3, 6.7 Hz, 1H).
1-[(Z)-2-Undecenyl]piperidine ((Z)-15ba). 1H NMR (400 MHz,
C6D6) δ 1.0 (t, J ) 6.7 Hz, 3H), 1.39-1.48 (m, 14H), 1.66 (quintet, J
) 5.7 Hz, 4H), 2.20 (q, J ) 7.3 Hz, 2H), 2.48 (t, J ) 5.1 Hz, 4H),
3.10 (d, J ) 6.7 Hz, 2H), 5.64 (dtt, J ) 11.0, 7.3, 1.6 Hz, 1H), 5.77
(dtt, J ) 11.0, 6.7, 1.5 Hz, 1H); 13C NMR (67.8 MHz, CDCl3) δ 14.1,
22.6, 24.4, 26.0 (2C), 27.4, 29.3 (2C), 29.4, 29.5, 31.8, 54.5 (2C), 55.9,
126.3, 132.8. Anal. Calcd for C16H31N: C, 80.94; H, 13.16; N, 5.90.
Found: C, 80.81; H, 13.10; N, 5.74.
1-[1-(n-Octyl)-2-propenyl]piperidine (14ba). Compound 14ba
1
could not be isolated in a pure form. Partial H NMR spectra were
1
obtained from the mixture of (Z)-15ba. H NMR (400 MHz, C6D6) δ